The applicant seeks renewal of a K24 Mid-Career Investigator Award in patient-oriented research in order to continue to develop his career as a clinical researcher and to devote the effort and time necessary for the mentoring of young clinical researchers. During the initial 4 years of funding the applicant has been highly successful, both as a mentor and as a researcher. The application describes his established research and mentoring program and plans to continue those endeavors. The mentoring plan sets out 10 key areas around which the mentoring of every trainee is structured. These are: i) Ethical responsibilities and scientific integrity; ii) Research of background information; iii) Formulating a hypothesis; iv) Design and performance of an experiment; v) Data organization, storage and analysis; vi) Writing a paper; vii) Presenting findings at a meeting; viii) Reviewing the work of others; ix) Grant writing and x) Planning a career. The applicant describes how his individual resources, and those of the institution, are applied in order to assure a successful and productive training program. The applicant has an active, funded research program and devotes 80% of his time to clinical research. Institutional letters of support outline the applicant's scientific achievements, his contributions as a teacher and mentor, the outstanding intellectual and physical resources available to him, and that, if funded, he will be provided with continued protected time to perform research and mentor trainees. The overall goal of the investigator's research program is to define the genetic and non-genetic factors that determine the variability in human vascular response. One of several active research programs is described. This project, Genetic Basis of Altered Sensitivity to beta1-Adrenoceptor Antagonists, is funded through a Pharmacogenetics and Pharmacogenomics Knowledge Base (Pharm GKB) grant and builds on the applicant's previous work. It will test the overall hypothesis that variable sensitivity to beta-blockers is a result of genetic variability in the beta1-AR. The renewal of a K24 award will allow the investigator to continue to pursue a highly productive career as a patient-oriented researcher and mentor. The unique research environment, his established ongoing research program and commitment to mentoring will allow him to continue to contribute to the fostering of clinical research through the hands-on training of young investigators.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
2K24HL004012-06
Application #
6781328
Study Section
Special Emphasis Panel (ZHL1-CSR-J (F1))
Program Officer
Schucker, Beth
Project Start
1999-06-01
Project End
2009-05-31
Budget Start
2004-07-01
Budget End
2005-05-31
Support Year
6
Fiscal Year
2004
Total Cost
$86,387
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Li, Chun; Schwarz, Ute I; Ritchie, Marylyn D et al. (2009) Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Blood 113:3925-30
Solus, Joseph; Chung, Cecilia P; Oeser, Annette et al. (2008) Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 58:2662-9
Kurnik, Daniel; Li, Chun; Sofowora, Gbenga G et al. (2008) Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. Pharmacogenet Genomics 18:895-902
Chung, Cecilia P; Oeser, Annette; Raggi, Paolo et al. (2008) Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus. Clin Rheumatol 27:1227-33
Chung, Cecilia P; Oeser, Annette; Solus, Joseph F et al. (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196:756-63
Schwarz, Ute I; Ritchie, Marylyn D; Bradford, Yuki et al. (2008) Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 358:999-1008
Chung, Cecilia P; Solus, Joseph F; Oeser, Annette et al. (2008) N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification. J Rheumatol 35:1314-9
Chung, Cecilia P; Oeser, Annette; Solus, Joseph F et al. (2008) Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum 58:2105-12
Avalos, I; Chung, C P; Oeser, A et al. (2007) Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 16:195-200
Chung, Cecilia P; Avalos, Ingrid; Oeser, Annette et al. (2007) High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66:208-14

Showing the most recent 10 out of 59 publications